- Fangzhou appointed Wang Haijiao as chief executive officer and executive director, effective March 26, 2026.
- Wang Haijiao previously served as deputy general manager, investment committee member, and executive partner at GTJA Investment Group after joining in 2014.
- He earlier worked as an investment director at Dragon Rise Capital from 2012 to 2014.
- Wang Haijiao is also a director of Guangzhou LBP Medicine Science & Technology (688393.SH).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260326-12069570), on March 26, 2026, and is solely responsible for the information contained therein.
Comments